Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

about

Fulvestrant in advanced breast cancer: evidence to date and place in therapy.Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2- metastatic breast cancer.A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers.

P2860

Q33887675-9D2F8B37-C557-44A7-9CDA-C37F09EA8DF2 Q38661473-CCB4F2E0-9437-41D4-9D47-20A013A067FF Q47825566-22A3C827-6E98-4918-87E1-F66D05650F51

P2860

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

Item

http://www.wikidata.org/entity/Q39172983

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@en

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@nl

type

Item

label

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@en

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@nl

prefLabel

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@en

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@nl

P1476

Enhancing Endocrine Therapy Co ...... /HER2- Advanced Breast Cancer.

@en

P2093

Alexander Paterson

http://www.w3.org/2001/XMLSchema#string

Christine Simmons

http://www.w3.org/2001/XMLSchema#string

Daniel Rayson

http://www.w3.org/2001/XMLSchema#string

Deanna McLeod

http://www.w3.org/2001/XMLSchema#string

Kathleen I Pritchard

http://www.w3.org/2001/XMLSchema#string

Louise Provencher

http://www.w3.org/2001/XMLSchema#string

Stephen K Chia

http://www.w3.org/2001/XMLSchema#string

P2860

Combination anastrozole and fulvestrant in metastatic breast cancer

The sequential use of endocrine treatment for advanced breast cancer: where are we?

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Everolimus plus exemestane for the treatment of advanced breast cancer: a review of subanalyses from BOLERO-2

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal

Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer.

Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood

Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement

P304

12-24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2016-0185

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27864574

http://www.w3.org/2001/XMLSchema#string

P932

5313264

http://www.w3.org/2001/XMLSchema#string

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

about

P2860

P2860

Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932